Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELPHI: TMC114/ritonavir in pediatric HIV
NCT00355524Phase 2Completed
- Sponsor
- Tibotec
- Start
- Jun 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Jun 2006; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00355524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355524.